首页|假尿苷修饰体外转录mRNA在翻译过程中发生的+1核糖体框架移码

假尿苷修饰体外转录mRNA在翻译过程中发生的+1核糖体框架移码

扫码查看
为应对世界范围内的COVID-19疫情,假尿苷(Ψ)修饰的体外转录mRNA(Ψ-IVT-mRNA)被授权应用于SARS-Cov-2 mRNA疫苗。最近,Ψ-IVT-mRNA被发现在翻译蛋白质时发生核糖体"滞顿",导致+1核糖体移码,在体外和体内翻译出异常的蛋白质。在接种SARS-Cov-2 mRNA疫苗的人群,这种异常蛋白可能激发脱靶T细胞反应或抗体反应或产生其它意想不到的副作用。这一发现对研制有效"安全"的mRNA疫苗/药物有"警示"和指导意义。
Pseudouridine-modified in vitro-transcribed mRNA Caused+1 Ribosomal Frameshifting During Protein Translation
Pseudouridine(Ψ)-modified in vitro-transcribed mRNA(Ψ-IVT-mRNA)is used in two li-censed SARS-CoV-2 mRNA vaccines in response to the COVID-19 pandemic worldwide.Recently the Ψ-IVT-mRNA has been demonstrated to cause ribosome stalling and lead to+1 ribosomal frameshifting both in vitro and in vivo,resulting in aberrant protein products.The aberrant proteins may have the potential to induce off-target T-cell or antibody responses and other unintended side effects in people vaccinated with SARS-CoV-2 mRNA vaccines.The finding highlights a key aspect of developing mRNA-based vaccines/therapeutics with improved outcomes.

SARS-CoV-2 vaccinesin vitro transcribed mRNApseudouracil modificationribosomal frameshifting

于永利

展开 >

吉林大学基础医学院免疫系,长春 130021

SARS-CoV-2疫苗 体外转录mRNA 假尿苷修饰 核糖体框架移码

2024

中国生物化学与分子生物学报
中国生物化学与分子生物学会 北京大学

中国生物化学与分子生物学报

CSTPCD北大核心
影响因子:0.617
ISSN:1007-7626
年,卷(期):2024.40(3)
  • 32